
Prestige Consumer Healthcare Inc.: updates and filings
Price
$49.63
November 20, 2026Market cap $2.4B
What Ploutos Investor adds for Prestige Consumer Healthcare
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from FY2010
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Nov 5, 2026next Feb 5, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
November 2026
August 2026
July 2026
May 2026
March 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 16, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Nov 5, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 5, 2026Results of operations, Regulation FD disclosureForm8-K
- Aug 14, 2026Officer or director changeForm8-K
- Aug 6, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Aug 6, 2026Results of operations, Regulation FD disclosureForm8-K
- Jul 15, 2026Material agreement entered, new material financial obligationForm8-K
- Jul 9, 2026Financial statements and exhibits (amendment)Form8-K/A
- Jul 7, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Jul 6, 2026Material agreement entered, new material financial obligation, Regulation FD disclosureForm8-K
- Jun 30, 2026Financial statements and exhibits (amendment)Form8-K/A
- Jun 29, 2026Annual report to shareholdersfor the period to Mar 31, 2026FormARS
- Jun 29, 2026Annual meeting proxy statementFormDEF 14A
- Jun 16, 2026Material agreement entered, acquisition or disposal of assets, new material financial obligation, other material eventsForm8-K
- May 14, 2026Annual reportfor the period to Mar 31, 2026Form10-K
- May 13, 2026Material agreement entered, results of operations, Regulation FD disclosureForm8-K
- Apr 30, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Apr 29, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Mar 27, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Mar 20, 2026Material agreement entered, Regulation FD disclosure, other material eventsForm8-K
- Feb 13, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Feb 5, 2026Quarterly reportfor the period to Dec 31, 2025Form10-Q
- Feb 5, 2026Results of operations, Regulation FD disclosureForm8-K
- Nov 14, 2025Over-5% holder statement (passive)FormSCHEDULE 13G
- Nov 6, 2025Quarterly reportfor the period to Sep 30, 2025Form10-Q
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 16, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Nov 5, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 5, 2026 | 8-K | Results of operations, Regulation FD disclosure | Document |
| Aug 14, 2026 | 8-K | Officer or director change | Document |
| Aug 6, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Aug 6, 2026 | 8-K | Results of operations, Regulation FD disclosure | Document |
| Jul 15, 2026 | 8-K | Material agreement entered, new material financial obligation | Document |
| Jul 9, 2026 | 8-K/A | Financial statements and exhibits (amendment) | Document |
| Jul 7, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Jul 6, 2026 | 8-K | Material agreement entered, new material financial obligation, Regulation FD disclosure | Document |
| Jun 30, 2026 | 8-K/A | Financial statements and exhibits (amendment) | Document |
| Jun 29, 2026 | ARS | Annual report to shareholdersfor the period to Mar 31, 2026 | Document |
| Jun 29, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Jun 16, 2026 | 8-K | Material agreement entered, acquisition or disposal of assets, new material financial obligation, other material events | Document |
| May 14, 2026 | 10-K | Annual reportfor the period to Mar 31, 2026 | Document |
| May 13, 2026 | 8-K | Material agreement entered, results of operations, Regulation FD disclosure | Document |
| Apr 30, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Apr 29, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Mar 27, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Mar 20, 2026 | 8-K | Material agreement entered, Regulation FD disclosure, other material events | Document |
| Feb 13, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Feb 5, 2026 | 10-Q | Quarterly reportfor the period to Dec 31, 2025 | Document |
| Feb 5, 2026 | 8-K | Results of operations, Regulation FD disclosure | Document |
| Nov 14, 2025 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Nov 6, 2025 | 10-Q | Quarterly reportfor the period to Sep 30, 2025 | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Jul 28, 2004.
The full analysis
What do Prestige Consumer Healthcare's filings show?
The filings are where every one of Prestige Consumer Healthcare's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.